Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Characteristics of patients with colorectal cancer and liver metastases undergoing SIR therapy

From: Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

  Median Range
Age 62.6 years 35.3 - 77.9 years
Time to SIRT after primary diagnosis 25 months 6-140
  Number Percentage (%)
Patients 49 100
Gender   
   Female 16 32.7
   Male 33 67.3
Localisation of primary tumor   
   Colon 11 22.5
   Sigma 22 44.0
   Rectum 16 32.5
Chemotherapies before SIRT   
FOLFOX 42 85.7
FOLFIRI 47 95.9
Therapy response   
   REM 9 18.4
   SD 5 10.2
   PD 35 71.4
   Progression defining   
   liver metastases 19 54.3
   extrahepatic manifestation 6 17.1
   deceased 10 28.6
One year survival*   
   Yes 22 45.8
   No 26 54.2
  Median 95% Conf. Interval
Overall survival 8.8 months 5.1-18.1
  1. * one patient lost to follow-up